Accuracy of interferon gamma release assays for the COVID-19 immunity assessment

被引:3
|
作者
Stieber, Francis [1 ]
Allen, Nadia [1 ]
Carpenter, Kara [1 ]
Howard, Jenny [1 ]
Alagna, Riccardo [2 ]
Manissero, Davide [3 ]
Nikolayevskyy, Vladyslav [3 ]
机构
[1] QIAGEN Sci Inc, 19300 Germantown Rd, Germantown, MD 20874 USA
[2] QIAGEN SRL, Via Filippo Sassetti 16, I-20124 Milan, Italy
[3] QIAGEN Manchester, Citylabs 2-0 Hathersage Rd, Manchester M13 0BH, Lancs, England
关键词
SARS-CoV-2; IGRA; T-cell immunity;
D O I
10.1016/j.jviromet.2022.114472
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Emerging evidence suggests that T-cells play a significant role in COVID-19 immunity both in the context of natural infection and vaccination. Easy to use IGRA assays including QFN SARS are considered attractive alternatives to more "traditional" but laborious methods for detection of SARS-CoV-2-specific T-cell responses. In our Letter we are proposing explanations to an apparently lower than expected T-cell responses (44 % reactive individuals) reported by Kruttgen et al in a small cohort of healthy double vaccinated individuals. These results could have been affected by reporting raw optical density values instead of calculated Interferon-gamma concentrations which is supported by unexpectedly low mitogen responses in healthy individuals. This study highlights an importance of adhering to good laboratory practice principles as well as overall importance of accurate T-cell immunity assessment using IGRA assays.
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Cell mediated immunity in COVID-19 patients evaluated by Interferon Gamma Release Assay (IGRA)
    Petrov, S.
    Kalfova, T.
    Bozhkova, M.
    Taskov, H.
    Murdjeva, M.
    JOURNAL OF IMAB, 2022, 22 : 82 - 85
  • [2] Interferon Gamma Release Assay Mitogen Responses in COVID-19
    Coppock, Dagan
    Zurlo, Claire E.
    Meloni, Jenna M.
    Goss, Sara L.
    Zurlo, John J.
    Pettengill, Matthew A.
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2022, 30 (01)
  • [3] Interferon gamma release assay results and outcomes in COVID-19 patients
    Kang, S.
    Eather, G.
    Qureshi, F.
    Beckingham, G.
    Scott, J.
    RESPIROLOGY, 2023, 28 : 231 - 231
  • [4] Evaluation of ichroma™ COVID-19 interferon gamma release assay for detection of vaccine-induced immunity in healthcare workers
    Lim, Yong Kwan
    Kweon, Oh Joo
    Choi, Yoojeong
    Kim, Tae-Hyoung
    Lee, Mi-Kyung
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2023, 61 (03) : 503 - 509
  • [5] Prevalence of indeterminate tuberculosis interferon-gamma release assays in COVID-19 patients: Systematic review and meta-analysis
    Ben Tekaya, Aicha
    Jerbi, Ameni
    Ben Sassi, Mouna
    Mokaddem, Salma
    Mahmoud, Ines
    Dziri, Chedli
    Abdelmoula, Leila
    HEALTH SCIENCE REPORTS, 2023, 6 (12)
  • [6] Interferon gamma and Interleukin 8 in COVID-19
    Mechi, F.
    Ghozzi, M.
    Melayah, S.
    Taamalia, M.
    Ghedira, I.
    CLINICA CHIMICA ACTA, 2024, 558
  • [7] Interferon-Gamma Release Assays
    Belknap, Robert
    Daley, Charles L.
    CLINICS IN LABORATORY MEDICINE, 2014, 34 (02) : 337 - +
  • [8] Interferon-gamma release assays
    Schablon, Anja
    Nienhaus, A.
    Loebermann, M.
    Reisinger, E. C.
    Frank, W.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2007, 132 (42) : 2225 - 2225
  • [9] Interferon gamma runs interference on persistent COVID-19
    Elliott, Eric Isaac
    Wang, Andrew
    MED, 2021, 2 (10): : 1111 - 1113
  • [10] Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination
    Kurteva, Ekaterina
    Vasilev, Georgi
    Tumangelova-Yuzeir, Kalina
    Ivanova, Irena
    Ivanova-Todorova, Ekaterina
    Velikova, Tsvetelina
    Kyurkchiev, Dobroslav
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (03) : 449 - 456